92 related articles for article (PubMed ID: 16579731)
1. Influence of concomitant food intake on the excretion of orally administered myo-inositol hexaphosphate in humans.
Grases F; Costa-Bauza A; Perelló J; Isern B; Vucenik I; Valiente M; Muñoz JA; Prieto RM
J Med Food; 2006; 9(1):72-6. PubMed ID: 16579731
[TBL] [Abstract][Full Text] [Related]
2. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin in humans.
Grases F; Isern B; Perelló J; Sanchis P; Prieto RM; Costa-Bauzà A
Pharmazie; 2006 Jul; 61(7):652. PubMed ID: 16889078
[TBL] [Abstract][Full Text] [Related]
3. Intracellular and extracellular myo-inositol hexakisphosphate (InsP6), from rats to humans.
Grases F; Costa-Bauza A; Prieto RM
Anticancer Res; 2005; 25(3c):2593-7. PubMed ID: 16080499
[TBL] [Abstract][Full Text] [Related]
4. Inositol hexakisphosphate in urine: the relationship between oral intake and urinary excretion.
Grases F; Simonet BM; March JG; Prieto RM
BJU Int; 2000 Jan; 85(1):138-42. PubMed ID: 10619962
[TBL] [Abstract][Full Text] [Related]
5. Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats.
Grases F; Perelló J; Prieto RM; Simonet BM; Torres JJ
Life Sci; 2004 May; 75(1):11-9. PubMed ID: 15102518
[TBL] [Abstract][Full Text] [Related]
6. Intake of myo-inositol hexaphosphate and urinary excretion of inositol phosphates in Wistar rats: Gavage vs. oral administration with sugar.
Grases F; Costa-Bauzá A; Berga F; Gomila RM; Martorell G; Martínez-Cignoni MR
PLoS One; 2019; 14(10):e0223959. PubMed ID: 31626632
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of inositol phosphates in urine after topical administration of myo-inositol hexaphosphate to female Wistar rats.
Grases F; Costa-Bauzá A; Berga F; Rodríguez A; Gomila RM; Martorell G; Martínez-Cignoni MR
Life Sci; 2018 Jan; 192():33-37. PubMed ID: 29155299
[TBL] [Abstract][Full Text] [Related]
8. Absorption and excretion of orally administered inositol hexaphosphate (IP(6) or phytate) in humans.
Grases F; Simonet BM; Vucenik I; Prieto RM; Costa-Bauzá A; March JG; Shamsuddin AM
Biofactors; 2001; 15(1):53-61. PubMed ID: 11673644
[TBL] [Abstract][Full Text] [Related]
9. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin: study of the matrix effects. mechanism of phytate topical absorption.
Grases F; Isern B; Perelló J; Sanchis P; Prieto RM
Front Biosci; 2005 Jan; 10():799-802. PubMed ID: 15569619
[TBL] [Abstract][Full Text] [Related]
10. Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications.
Grases F; Costa-Bauza A
Molecules; 2019 Dec; 24(24):. PubMed ID: 31817119
[TBL] [Abstract][Full Text] [Related]
11. Study of the absorption of myo-inositol hexakisphosphate (InsP6) through the skin.
Grases F; Perelló J; Isern B; Prieto RM
Biol Pharm Bull; 2005 Apr; 28(4):764-7. PubMed ID: 15802828
[TBL] [Abstract][Full Text] [Related]
12. [3H]phytic acid (inositol hexaphosphate) is absorbed and distributed to various tissues in rats.
Sakamoto K; Vucenik I; Shamsuddin AM
J Nutr; 1993 Apr; 123(4):713-20. PubMed ID: 8463873
[TBL] [Abstract][Full Text] [Related]
13. Phytate levels in diverse rat tissues: influence of dietary phytate.
Grases F; Simonet BM; Prieto RM; March JG
Br J Nutr; 2001 Aug; 86(2):225-31. PubMed ID: 11502236
[TBL] [Abstract][Full Text] [Related]
14. [3H]inositol hexaphosphate (phytic acid) is rapidly absorbed and metabolized by murine and human malignant cells in vitro.
Vucenik I; Shamsuddin AM
J Nutr; 1994 Jun; 124(6):861-8. PubMed ID: 8207543
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid).
Sakamoto K; Venkatraman G; Shamsuddin AM
Carcinogenesis; 1993 Sep; 14(9):1815-9. PubMed ID: 7691427
[TBL] [Abstract][Full Text] [Related]
16. Effects of mineral and rapeseed phosphorus supplementation on phytate degradation in dairy cows.
Haese E; Müller K; Steingass H; Schollenberger M; Rodehutscord M
Arch Anim Nutr; 2014 Dec; 68(6):478-91. PubMed ID: 25319492
[TBL] [Abstract][Full Text] [Related]
17. Dietary phytate and mineral bioavailability.
Grases F; Simonet BM; Prieto RM; March JG
J Trace Elem Med Biol; 2001; 15(4):221-8. PubMed ID: 11846011
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats.
Ullah A; Shamsuddin AM
Carcinogenesis; 1990 Dec; 11(12):2219-22. PubMed ID: 2265472
[TBL] [Abstract][Full Text] [Related]
19. Inositol hexaphosphate (InsP6) as an effective topical treatment for patients receiving adjuvant chemotherapy after breast surgery.
Proietti S; Pasta V; Cucina A; Aragona C; Palombi E; Vucenik I; Bizzarri M
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):43-50. PubMed ID: 28724186
[TBL] [Abstract][Full Text] [Related]
20. Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats.
Grases F; Sanchis P; Perello J; Isern B; Prieto RM; Fernandez-Palomeque C; Fiol M; Bonnin O; Torres JJ
Front Biosci; 2006 Jan; 11():136-42. PubMed ID: 16146720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
